Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

FDA clears new formulation of Imitrex

Sep. 1, 1997

FKBP12 inhibitors in the pipeline at Guilford

Aug. 29, 1997

New Parkinson's disease treatment option now available in Canada

Aug. 28, 1997

Morphine derivatives discovered by Nycomed

Aug. 28, 1997

Tasmar approved in EU for Parkinson's disease

Aug. 28, 1997

Neurochemical actions of ARL-12495AA, the active metabolite of remacemide

Aug. 28, 1997

Immune Response's TCR vaccine evaluated in MS patients

Aug. 28, 1997

Calcium channel antagonist AJ-3941 for treatment of stroke

Aug. 27, 1997

S-15535 tested in preclinical models of anxiety and depression

Aug. 27, 1997

New treatment option for cancer pain

Aug. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...